Elenco dei brevetti non coperti da certificato complementare di protezione ITA EP EP633784 EP652766 EP656775 EP656780 EP658118 EP591710 EP593897 EP668851 EP670719 EP602454 EP674621 EP680320 N TRADUZIONE EP TITOLO PRINCIPIO ATTIVO HEPATITIS VACCINS CONTAINING 3-0 VACCINO ANTIEPATITE B RM2002B047565 DEACYLATED MONOPHOSPHORYL (RDNA) - ADIUVATO LIPID A ADSORBITO ORMONE DELLA HUMAN GROWTH HORMONE MI2008B025368 CRESCITA UMANA AQUEOUS FORMULATION RICOMBINANTE SUSTAINED RELEASE TABLETS BUPROPIONE RM1998B048516 CONTAINING BUPROPION CLORIDRATO MI1997B025294 MI2002B023364 SCADENZA 24/03/1993 24/03/2013 NUTROPIN 29/07/1993 29/07/2013 WELLBUTRIN ELONTRIL 13/08/1993 13/08/2013 FENDRIX ACIDO IBANDRONICO BONDRONAT 19/08/1993 19/08/2013 VACCINES AGAINST GROUP C NEISSERIA MENINGITIDIS VACCINO MENINGOCOCCICO GRUPPO C-TT CONIUGATO NEISVAC-C 30/08/1993 30/08/2013 MESNA MESNEX UROMITEXAN 13/09/1993 13/09/2013 MILTEFOSINE MILTEX 13/09/1993 13/09/2013 DEXKETOPROFENE TROMETAMOLO DESKETO ENANTYUM KETESSE 09/11/1993 09/11/2013 ATOVAQUONE E PROGUANILE MALARONE MALARONE BAMBINI 25/11/1993 25/11/2013 CAPECITABINA XELODA 01/12/1993 01/12/2013 FROVATRIPTAN AURADOL RILAMIG 16/12/1993 16/12/2013 ATORVASTATINA TOTALIP 20/12/1993 20/12/2013 INJECTION SOLUTIONS CONTAINING MESNA STABILIZED SOLUTIONS OF RM1995B052453 ALKYLPHOSPHOCHOLINE IN GLYCEROLALKYLETHER A NOVEL ARYLPROPIONIC DERIVATIVE, A PROCESS FOR THE MI1997B026105 PREPARATION AND THE USETHEREOF AS AN ANALGESIC AGENT COMBINATION OF ATOVAQUONE WITH PROGUANIL FOR THE RM2000B049688 TREATMENT OF PROTOZOAL INFECTIONS N-OXYCARBONYL SUBSTITUTED 5'MI1996B025352 DEOXY-5-FLUOROCYTIDINES ENANTIOMERS OF CARBAZOLE TO2003B069304 DERIVATIVES AS 5-HT1-LIKE AGONISTS Elenco aggiornato al 12.03.2014 DEPOSITO DRUGS CONTAINING DIPHOSPHONIC ACIDS AND SALTS THEREOF RM1996B048988 UD1999B083414 MARCHIO STABLE ORAL CI-981 FORMULATION AND PROCESS OF PREPARING SAME Pagina 1 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP678122 MI1999B027762 RECOMBINANT ANTI-VLA4 ANTIBODY MOLECULES NATALIZUMAB TYSABRI 07/01/1994 07/01/2014 EP693134 MI1997B027196 ARYLALKANOIC ACID RESOLUTION DEXKETOPROFENE TROMETAMOLO DESKETO ENANTYUM KETESSE 03/03/1994 03/03/2014 EP711154 MI2003B023458 BUPROPIONE CLORIDRATO WELLBUTRIN ELONTRIL 29/07/1994 29/07/2014 EP721335 MI2005B031917 CELLCEPT 27/09/1994 27/09/2014 EP721331 TO2002B067894 PROCESS I SYMBICORT SINESTIC 29/09/1994 29/09/2014 EP721332 TO2002B071434 PROCESS II SYMBICORT 29/09/1994 29/09/2014 EP722439 MI2002B030449 VIRACEPT 07/10/1994 07/10/2014 EP723444 TO1997B069936 LEVOBUPIVACAINE CHIROCAINE 13/10/1994 13/10/2014 EP723445 EP727210 TO1997B068421 TO2002B068244 13/10/1994 13/10/1994 13/10/2014 13/10/2014 MI2002B026144 LEVOBUPIVACAINE LEVOBUPIVACAINE PEGINTERFERONE ALFA2B CHIROCAINE CHIROCAINE EP730470 PEGINTRON 10/11/1994 10/11/2014 EP741565 MI2000B023698 HIV PROTEASE INHIBITORS LEVOBUPIVACAINE USEFUL FOR MANAGING CHRONIC PAIN ANALGESIC AGENT AND ITS USE ANALGESIC AGENT AND ITS USE IMPROVED INTERFERON POLYMER CONJUGATES PROCESS FOR PRODUCING S(+)IBUPROFEN PARTICLES DEXIBUPROFENE SERACTIL CP 26/01/1995 26/01/2015 EP742715 MI1999B023031 PAROXETINA EUTIMIL SEROXAT SEREUPIN 30/01/1995 30/01/2015 08/02/1995 08/02/2015 17/03/1995 17/03/2015 24/03/1995 24/03/2015 29/03/1995 29/03/2015 IT1274249 EP814787 TO2003B067243 EP754048 MI2001B024703 EP679718 MI2001B026410 Elenco aggiornato al 12.03.2014 STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING BUPROPION MYCOPHENOLATE MOFETIL HIGH DOSE ORAL SUSPENSIONS ORAL LIQUID COMPOSITIONS CONTAINING PAROXETINE RESINATE MICOFENOLATO MOFETILE BUDESONIDE + FORMOTEROL BUDESONIDE + FORMOTEROL NELFINAVIR SFORMULAZIONI FARMACEUTICHE A CARBOSSIMETILCISTEINA BASE DI CARBOSSIMETILCISTEINA FLUIFORT SCIROPPO SALE DI LISINA SALE DI LISINA MONOIDRATO OIL IN WATER EMULSIONS PROPOFOL DIPRIVAN CONTAINING PROPOFOL AND DISODIUM EDETATE TREATMENT OF PARTIAL GROWTH IGF-I INCRELEX HORMONE INSENSITIVITY SYNDROME PROCESS FOR PRODUCING ALPHA- INTERFERONE ALFA-2A ROFERON-A INTERFERON RICOMBINANTE Pagina 2 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP757684 EP773940 PROCESS FOR THE RM1999B050612 DIASTEREOSELECTIVE SYNTHESIS OF NUCLEOSIDE ANALOGUES PROCESS FOR SYNTHESIS OF TO2011B067180 SUBSTITUTED SULPHOXIDES HUMANIZED ANTIBODIES AGAINST RESPIRATORY SYNCYTIAL VIRUS EP783525 MI2006B037253 EP779805 MI2002B020731 EP777495 RM2000B050463 EP810877 RM2002B048137 HEPATITIS B VACCINE EP736303 MI1999B027582 INTERFERON SOLUTION EP1394179 MI2006B032442 EP843672 TO2003B067575 EP843673 TO2002B067246 SUSTAINED RELEASE OF PEPTIDES FROM PHARMACEUTICAL COMPOSITIONS STABLE, AQUEOUS ALFA INTERFERON SOLUTION FORMULATIONS PROCESS FOR PRODUCING ERYTHROPOIETIN FREE FROM ANIMAL PROTEINS ONE POT SYNTHESIS OF 2OXAZOLIDINONE DERIVATIVES ONE POT SYNTHESIS OF 2OXAZOLIDINONE DERIVATIVES PURIFIED HEPARIN FRACTIONS, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME EP623629 TO1996B070023 EP869796 A GLIBENCLAMIDE-METFORMIN MI2003B027399 COMBINATION FOR THE TREATMENT OF DIABETES MELLITUS OF EP882024 MI2002B021132 Elenco aggiornato al 12.03.2014 RETROVIRAL PROTEASE INHIBITING COMPOUNDS LAMIVUDINA ZEFFIX 21/04/1995 21/04/2015 ESOMEPRAZOLE MG NEXIUM COMPRESSE 03/07/1995 03/07/2015 PALIVIZUMAB SYNAGIS 09/08/1995 09/08/2015 LANREOTIDE IPSTYL 31/08/1995 31/08/2015 INTERFERONE ALFA-2B RICOMBINANTE INTRON A 10/10/1995 10/10/2015 15/02/1996 15/02/2016 FENDRIX INTERFERONE ALFA-2A RICOMBINANTE ROFERON-A 30/03/1996 30/03/2016 METOSSIPOLIETILENGLIC OLE-EPOETINA BETA MIRCERA 10/05/1996 10/05/2016 ZOLMITRIPTAN ZOMIG 02/08/1996 02/08/2016 ZOLMITRIPTAN ZOMIG 02/08/1996 02/08/2016 NADROPARINA CALCICA FRAXIPARINA FRAXODI SELEPARINA SELEDIE 21/08/1996 21/08/2016 GLIBENCLAMIDE; METFORMINA GLICONORM 07/11/1996 07/11/2016 LOPINAVIR/RITONAVIR KALETRA 06/12/1996 06/12/2016 Pagina 3 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP814797 MI2003B023684 PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING ALKYLAMMONIUM SALTS OF 2ARYLP EP890359 MI2002B027236 TABLETS CONTAINING BETA-LACTAM ANTIBIOTIC AND PROCESS FOR PRODUCING THE SAME CEFIXIME CEFIXORAL SUPRACEF UNIXIME SUPRAX 21/02/1997 21/02/2017 EP936913 MI2012B031906 ORAL PHARMACEUTICAL PREPARATION CONTAINING IBANDRONAT ACIDO IBANDRONICO BONDRONAT 21/04/1997 21/04/2017 EP809996 MI2003B025999 INTERFERON CONJUGATES PEGINTERFERONE ALFA2A PEGASYS 22/05/1997 22/05/2017 QUETIAPINE SEROQUEL (XR) 27/05/1997 27/05/2017 ETORICOXIB ARCOXIA 08/07/1997 08/07/2017 INTERFERONE B-1A AVONEX 23/12/1997 23/12/2017 BUDESONIDE + FORMOTEROL SYMBICORT SINESTIC OXIS 13/01/1998 13/01/2018 BUDESONIDE + FORMOTEROL SYMBICORT SINESTIC 13/01/1998 13/01/2018 BUDESONIDE PULMAXAN 13/01/1998 13/01/2018 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A DIBENZOTHIAZEPINE DER SUBSTITUTED PYRIDINES AS SELECTIVE CYCLOOXYGENASE-2 INHIBITORS STABLE LIQUID INTERFERON FORMULATIONS NEW FORMULATION FOR INHALATION HAVING A POURED BULK DENSITY OF 0.28 TO 0.38 G/ML, A PROCESS FOR PREPARING THE FORMULATION AND THE USE THEREOF EP907364 TO2002B071892 EP912518 RM2003B052451 EP948358 MI2012B020624 EP1007017 TO2011B067562 EP1009394 NEW FORMULATION FOR INHALATION HAVING A POURED TO2004B068272 BULK DENSITY OF FROM 0.28 TO0.38 COMPRISING FORMOTEROL EP1019033 TO2008B069255 Elenco aggiornato al 12.03.2014 NEW FORMULATION FOR INHALATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, COMPRISING BUDESONIDE KETOPROFENE SALE DI LISINA ARTROSILENE 160 MG/2 ML SOLUZIONE INIETTABILE 23/12/1996 23/12/2016 Pagina 4 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP989850 EP921796 USE OF PRAMIPEXOLE IN THE MI2005B019019 TREATMENT OF RESTLESS LEGS SYNDROME TETRAHYDROLIPSTATIN CONTAINING MI2001B021095 COMPOSITIONS PRAMIPEXOLO MIRAPEXIN 16/01/1998 16/01/2018 ORLISTAT XENICAL 24/01/1998 24/01/2018 SYMBICORT SINESTIC 13/03/1998 13/03/2018 ASMANEX 16/03/1998 16/03/2018 SYMBICORT SINESTIC 19/03/1998 19/03/2018 ZEFFIX 20/03/1998 20/03/2018 NUVARING 09/04/1998 09/04/2018 BECLOMETASONE DIPROPIONATO BUDESONIDE CLENIL CLENIL JET BUDIAIR DESO MIFLO: SOLUZ PRESS PER INAL 10/06/1998 10/06/2018 OMEPRAZOLE NA LOSEC I.V. 11/06/1998 11/06/2018 GANIRELIX ORGALUTRAN 16/06/1998 16/06/2018 TICAGRELOR BRILIQUE 15/07/1998 15/07/2018 PIROXICAM BETACICLODESTRINA MELEVODOPA + CARBIDOPA BREXIN CICLADOL SIRIO SOLMEDO CPR EFFERVESCENTI 23/07/1998 23/07/2018 ADEFOVIR HEPSERA 23/07/1998 23/07/2018 TENOFOVIR DISOPROXIL FUMARATE VIREAD 23/07/1998 23/07/2018 BUDESONIDE + FORMOTEROL MOMETASONE FUROATO BUDESONIDE + FORMOTEROL EP1007121 TO2003B071700 INHALATION DEVICE EP969816 RM2005B048363 PREPARATION OF POWDER AGGLOMERATES EP1017438 TO2004B072809 INHALATION DEVICE EP969815 RM2005B049653 PHARMACEUTICAL COMPOSITIONS EP876815 TO2002B068433 "DRUG DELIVERY SYSTEM FOR TWO ETONOGESTREL/ETINILE OR MORE ACTIVE SUBSTANCES" STRADIOLO EP920302 MI2006B031755 EP991641 TO2003B069262 EP994718 TO2005B072159 EP996621 TO2003B074119 EP1003486 MI2003B023025 EP996430 MI2003B021180 EP998480 MI2003B021181 Elenco aggiornato al 12.03.2014 PHARMACEUTICAL AEROSOL COMPOSITION CRYSTALLINE FORM OF OMEPRAZOLE SODIUM SALT GONADOTROPIN RELEASING HORMONE ANTAGONIST TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS PHARMACEUTICAL COMPOSITIONS CONTAINING AN EFFERVESCENT ACID-BASE COUPLE NUCLEOTIDE ANALOG COMPOSITIONS NUCLEOTIDE ANALOG COMPOSITION AND SYNTHESIS METHOD Pagina 5 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP1019058 MI2006B030048 EP0911038 TO2000B069880 EP1025083 RM2003B052101 NEVIRAPINA VIRAMUNE 11/08/1998 11/08/2018 LATTULOSIO PARAFFINA TRASITOL 06/10/1998 06/10/2018 TREPROSTINIL SODICO REMODULIN SOLUZIONE PER INFUSIONE 26/10/1998 26/10/2018 FORMULAZIONI DI APOMORFINA IN SOLUZIONE STABILI NEL TEMPO APOMORFINA APOFIN 30/10/1998 30/10/2018 TO2004B068714 STERILIZATION OF GLUCOCORTICOSTEROIDS BUDESONIDE PULMAXAN 11/11/1998 11/11/2018 RM2004B048110 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-PTOLUOYLPYRROLE-2ACETAMIDOACETI ESTER (MED 15) AMTOLMETINA GUACIL EUFANS 16/12/1998 16/12/2018 COMPOSIZIONI FARMACEUTICHE PER IL TRATTAMENTO DEL DIABETE MELLITO DI TIPO II METFORMINA + GLIBENCLAMIDE GLIBOMET 24/12/1998 24/12/2018 FORMOTEROLO ATIMOS BOREAX LIFEROL: POLVERE PER INALAZIONE 05/03/1999 05/03/2019 IT 1303684 EP1032396 EP1082304 PHARMACEUTICAL SUSPENSION COMPRISING NEVIRAPINE HEMIHYDRATE ANHYDROUS COMPOSITION COMPRISING LACTULOSE PROCESS FOR STEREOSELECTIVE SYNTHESIS OF PROSTACYCLIN DERIVATIVES IT1327107 EP1158958 MI2007B030279 IMPROVED POWDERY PHARMACEUTICAL COMPOSITIONS FOR INHALATION EP1066049 MI2003B029801 PHARMACEUTICAL COMPOSITIONS FOR PROLONGED PEPTIDE RELEASE AND PREPARATION METHOD LANREOTIDE IPSTYL 22/03/1999 22/03/2019 EP1066059 RM2005B050040 FORMULATIONS FOR PROTECTION OF PEG-INTERFERON ALPHA CONJUGATES PEGINTERFERONE ALFA2B PEGINTRON 24/03/1999 24/03/2019 EP1067979 TO2004B071880 INHALATION DEVICE BUDESONIDE + FORMOTEROL SYMBICORT SINESTIC 30/03/1999 30/03/2019 MI2006B019135 MEASURING PROBE FOR USE IN MEASURING THE TEMPERATURE OR MASS OF A FLOWING MEDIUM AND PROCESS FOR ITS MANUFACTURE. RIBAVIRIN COPEGUS 29/05/1999 29/05/2019 EP1087778 Elenco aggiornato al 12.03.2014 Pagina 6 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione TO2008B069358 USE OF A COMPOSITION COMPRISING FORMOTEROL AND BUDESONIDE FOR THE PREVENTION OR TREATMENT OF AN ACUTE CONDITION OF ASTHMA BUDESONIDE + FORMOTEROL SYMBICORT SINESTIC 10/06/1999 10/06/2019 MI2005B028925 PHARMACEUTICAL FORMULATIONS COMPRISING BECLOMETHASONE DIPROPIONATE FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE BECLOMETASONE DIPROPIONATO BECOLEX BIDICLIN CLIPPER: CPR RIVESTITE 20/07/1999 20/07/2019 EP1486209 MI2008B029137 PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE BECLOMETASONE DIPROPIONATO BECOLEX BIDICLIN CLIPPER: CLISMI 20/07/1999 20/07/2019 EP1102745 MI2004B028761 A PROCESS FOR THE PREPARATION OF ZOFENOPRIL CALCIUM SALT ZOFENOPRIL CALCIO BIFRIL ZANTIPRESS ZOPRANOL ZOPRAZIDE BIFRIZIDE 30/07/1999 30/07/2019 EP1096937 TO2005B068384 RANOLAZINA RANEXA 09/09/1999 09/09/2019 EP1113831 TO2004B072801 LANREOTIDE IPSTYL 17/09/1999 17/09/2019 EP970703 RM2003B051953 USE OF METAL CHELATING AGENTS TO STABILIZE PREPARATIONS CONTAINING INTERFERON INTERFERONE ALFA-2B RICOMBINANTE INTRON A 30/09/1999 30/09/2019 EP1070503 TO2005B071473 COMPOSITIONS COMPRISING LOW MOLECULAR WEIGHT HEPARIN BEMIPARINA SODICA IVOR 13/10/1999 13/10/2019 MI2007B024432 A PROCESS FOR THE PREPARATION OF STERILE THERAPEUTICALLY ACCEPTABLE BECLOMETHASONE DIPROPIONATE BECLOMETASONE DIPROPIONATO BECLOMETASONE DIPROPIONATO + SALBUTAMOLO BECLONEB CLENIL PRONTINAL CLENIL COMPOSITUM: SOSP PER NEBULIZZ 28/10/1999 28/10/2019 EP1085877 EP1100481 EP1126823 Elenco aggiornato al 12.03.2014 SUSTAINED RELEASE RANOLAZINE FORMULATIONS SYRINGES FOR ADMINISTERING PASTY OR SEMI-SOLID FORMULATIONS Pagina 7 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP1124544 TO2003B070773 DRY POWDER PHARMACEUTICAL FORMULATION BUDESONIDE EP1131051 MI2006B023258 PRESSURISED METERED DOSE INHALERS (MDI) BUDESONIDE EP1140117 RM2003B050098 ACICLOVIR COMPOSITIONS CONTAINING DIMETHICONE ACICLOVIR EP1178808 COMPOSIZIONE FARMACEUTICA NON ACQUOSA PER USO CUTANEO PER IL TRATTAMENTO DELLA RM2012B050497 PSORIASI COMPRENDENTE UNA VITAMINA D, UN CORTICOSTEROIDE ED UN COMPONENTE DI SOLVENTE EP2455083 TO2013B071848 EP1155015 TO2009B067185 EP1189620 TO2004B071461 EP1020460 TO2009B070518 EP1020461 TO2009B070517 EP1181930 UD2004B083348 Elenco aggiornato al 12.03.2014 CALCIPOTRIOLO /BETAMETASONE DIPROPIONATO RHINOCORT BUDIAIR DESO MIFLO: SOLUZ PRESS PER INAL ZOVIRAXLABIALE CYCLOVIRANLABIALE EFRIVIRALLABIALE DOVOBET UNGUENTO TOKEN UNGUENTO XAMIOL GEL DOVOBET GEL COMPOSIZIONE FARMACEUTICA PER DOVOBET® CALCIPOTRIOLO/BETAM USO CUTANEO COMPRENDENTE UNGUENTO ETASONE CALCIPOTRIOLO E BETAMETASONE TOKEN® UNGUENTO DIPROPIONATO PER IL TRATTAMENTO DELLA XAMIOL®GEL PSORIASI DOVOBET ®GEL PROCESS FOR THE PRODUCTION OF TERT-BUTYL (E)-(6-¿¿2-¿¿4-(4FLUOROPHENYL)-6-ISOPROPYL-2ROSUVASTATIN CRESTOR ¿¿METHYL(METHYLSULFONYL)AMIN O PYRIMIDIN-5-YL VINYL (4R,6S)-2,2DIMETHYL¿¿1,3 DIOXAN-4YL)ACETATE FORMULATION COMPRISING TESTOSTERONE ANDRIOL TESTOSTERON UNDECANOATE AND UNDECANOATO CASTOR OIL THE SODIUM SALT OF THE (-)ESOMEPRAZOLE NA NEXIUM I.V. ENANTIOMER OF OMEPRAZOLE MAGNESIUM SALT OF THE (-)NEXIUM COMPRESSE ENANTIOMER OF OMEPRAZOLE AND ESOMEPRAZOLE MG ITS USE PATCH KETOPROFENE KEPLAT 03/11/1999 03/11/2019 23/11/1999 23/11/2019 21/12/1999 21/12/2019 27/01/2000 27/01/2020 27/01/2000 27/01/2020 15/02/2000 15/02/2020 27/03/2000 27/03/2020 18/04/2000 18/04/2020 18/04/2000 18/04/2020 27/04/2000 27/04/2020 Pagina 8 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione PREPARAZIONI PER L'USO DISODIO CLODRONATO, INTRAMUSCOLARE DI BISFOSFONATI LIDOCAINA CLORIDRATO IT1318540 EP1223918 EP1323701 EP1233948 EP1332206 PHARMACEUTICAL COMPOSITIONS COMPRISING A HMG COA REDUCTASE INHIBITOR METHODS FOR CRYSTALLIZATION OF TO2009B071989 HYDROXYCARBOXYLIC ACIDS STABLE POLYMORPH OF N-(3ETHYNYLPHENYLAMINO)-6,7-BIS(2METHOXYETHOXY)-4MI2009B022761 QUINAZOLINAMINE HYDROCHLORIDE, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF RECOMBINANT ALPHA-LIDURONIDASE, METHODS FOR PRODUCING AND PURIFYING THE MI2006B037460 SAME AND METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES THEREOF TO2003B068959 EP1237551 TO2005B069438 PHARMACEUTICAL FORMULATIONS CONTAINING ZOLMITRIPTAN EP1238664 TO2007B069749 ADHESIVE PREPARATIONS EP1244487 MI2007B019072 AEROSOL INHALER EP1250138 TO2005B073043 EP1190712 UD2004B089376 FULVESTRANT FORMULATION ORAL ONCE DAILY TRAMADOL BEADS COMPOSITION Elenco aggiornato al 12.03.2014 CLASTEON 26/05/2000 26/05/2020 ROSUVASTATIN CRESTOR 04/08/2000 04/08/2020 ROSUVASTATIN CRESTOR 04/08/2000 04/08/2020 ERLOTINIB TARCEVA 09/11/2000 09/11/2020 LARONIDASE ALDURAZYME 09/11/2000 09/11/2020 ZOLMITRIPTAN ZOMIG 28/11/2000 28/11/2020 KETOPROFENE BECLOMETASONE DIPROPIONATO BECLOMETASONE DIPROPIONATO + SALBUTAMOLO FULVESTRANT KEPLAT 15/12/2000 15/12/2020 CLENIL JET CLENIL COMP JET SOLUZ PRESS PER INAL CON EROGATORE JET 02/01/2001 02/01/2021 FASLODEX 08/01/2001 08/01/2021 TRAMADOL TRALODIE 14/02/2001 14/02/2021 Pagina 9 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione IT1304502 EP1272195 TO2005B073143 EP1272167 RM2008B049802 METODO PER PREPARARE UN GRANULATO EFFERVESCENTE COMPRENDENTE GLUCONATO DI FERRO, GRANULATO COSÌ OTTENUTO E COMPRESSE CHE LO CONTENGONO USE OF FULVESTRANT IN THE TREATMENT OF RESISTANT BREAST CANCER ROPINIROLE-CONTAINING HYDROPHILIC/LIPHILIC POLYMERIC MATRIX DOSAGE FORMULATION GLUCONATO FERROSO GLUCOFERRO CPR 29/03/2001 29/03/2021 FULVESTRANT FASLODEX 02/04/2001 02/04/2021 ROPINIROLO REQUIP 12/04/2001 12/04/2021 BECLOMETASONE DIPROPIONATO + FORMOTEROLO FORMOTEROLO ALABASTER FORMODUAL FOSTER INUVER ATIMOS BOREAX LIFEROL: POLVERE PER INALAZIONE 17/04/2001 17/04/2021 MIRCERA 08/05/2001 08/05/2021 18/05/2001 18/05/2021 02/07/2001 02/07/2021 EP1274406 MI2006B036540 PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD-PELLETS EP1311285 MI2005B025559 LIQUID PHARMACEUTICAL COMPOSITION CONTAINING AN ERYTHROPOIETIN DERIVATIVE METOSSIPOLIETILENGLIC OLE-EPOETINA BETA EP1157689 MI2009B021956 STABLE PHARMACEUTICAL SOLUTION FORMULATIONS FOR PRESSURISED METERED DOSE INHALERS FORMOTEROLO EP1273292 MI2004B029338 OPTIMISED FORMULATION OF TOBRAMYCIN FOR AEROSOLIZATION TOBRAMICINA EP1296645 MI2006B036039 EP1301201 MI2007B022525 Elenco aggiornato al 12.03.2014 METHODS FOR TREATING INFLAMMATION-MEDIATED CONDITIONS OF THE EYE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II ATIMOS BOREAX LIFEROL FORADIL EOLUS: SOLUZ PRESS PER INAL ACTITOB BRAMITOB TOBRINEB DESAMETASONE OZURDEX 03/07/2001 03/07/2021 ALGLUCOSIDASE ALFA MYOZYME 10/07/2001 10/07/2021 Pagina 10 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP1331927 COMPOSIZIONE TOPICA CONTENENTE ALMENO UNA TO2008B068153 VITAMINA D O UN ANALOGO DI UNA VITAMINA D E ALMENO UN CORTICOSTEROIDE EP1292281 MI2004B034406 EP1326862 MI2004B034837 EP1328538 TO2008B072720 IT1340100 NOVEL TIOTROPIUM-CONTAINING INHALATION POWDER MI2007B034598 EP1339409 USE OF ROSUVASTATIN (ZD-4522) IN TO2008B070491 THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA EP1339438 MI2005B034814 EP1343808 MI2006B036555 MI2011B030858 Elenco aggiornato al 12.03.2014 XAMIOL GEL DOVOBET GEL 26/09/2001 26/09/2021 TIOTROPIO BROMIDE SPIRIVA HANDIHALER 28/09/2001 28/09/2021 28/09/2001 28/09/2021 09/10/2001 09/10/2021 16/10/2001 16/10/2021 24/10/2001 24/10/2021 CRYSTALLINE MONOHYDRATE OF TIOTROPIUMBROMIDE, METHOD TIOTROPIO BROMIDE SPIRIVA FOR PRODUCING THE SAME AND MONOIDRATO THE USE THEREOF IN THE PRODUCTION OF A MEDICAMENT PROCESS AND INTERMEDIATES FOR FULVESTRANT FASLODEX THE PRODUCTION OF 7SUBSTITUTED ANTIESTROGENS COMPOSIZIONI FARMACEUTICHE ENALAPRIL CORIPREN ATOVER PER IL TRATTAMENTO MALEATO/LERCANIDIPIN ZANIPRIL LERCAPREL DELL'IPERTENSIONE ARTERIOSA A CLORIDRATO INHALATIVE SOLUTION TIOTROPIO BROMIDE SPIRIVA RESPIMAT FORMULATION CONTAINING A TIOTROPIUM SALT EP1333819 EP1467712 CALCIPOTRIOLO /BETAMETASONE DIPROPIONATO PREVENTING TRANSPLANT REJECTION IN THE EYE PROCESS FOR THE SYNTHESIS OF AN LHRH PEPTIDE BILAYER PHARMACEUTICAL TABLET COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE ROSUVASTATIN CRESTOR 16/11/2001 16/11/2021 DESAMETASONE OZURDEX 28/11/2001 28/11/2021 TRIPTORELINA DECAPEPTYL 19/12/2001 19/12/2021 TELMISARTAN + IDROCLOROTIAZIDE MICARDISPLUS 16/01/2002 16/01/2022 Pagina 11 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP1355636 EP1621198 EP1363928 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING NONSTEROIDAL ANTIPHLOGISTIC AGENTS TO2008B071506 CONTAINING CARBOXYL GROUPS, AND A METHOD FOR THE PRODUCTION OF THE SAME DERIVATI DI CARBOSTIRILE SOSTITUITO COME ANTAGONISTI TO2007B071431 DEL SOTTOTIPO DI RECETTORE 5HT1A PROCESS FOR THE PREPARATION OF MI2005B028581 (E)-5-(2-BROMOVINYL)-2'DEOXYURIDINE EP1505066 POLYMORPH OF ACID 4-[2-[4-[1-(2ETHOXYETHYL)-1H-BENZIMIDAZOLETO2007B068262 2-IL]-1-PIPERIDINYL]ETHYL]-ALPHA, ALPHA-DIMETHYL-BENZENEACETIC EP1238677 TO2006B067806 IT 1334343 IBUPROFENE IBUPAS 17/01/2002 17/01/2022 ARIPIPRAZOLO ABILIFY 29/01/2002 29/01/2022 BRIVUDINA BRIVIRAC ZECOVIR 21/02/2002 21/02/2022 BILASTINA ROBILAS AYRINAL 19/04/2002 19/04/2022 DIPRIVAN 02/05/2002 02/05/2022 CLODY 13/05/2002 13/05/2022 PARENTERAL FAT EMULSIONS PROPOFOL COMPRISING EDETATE AS PRESERVATIVE FORMULAZIONI DI BISFOSFONATI A CLODRONATO DISODICO USO INIETTABILE EP1407008 RM2009B048278 INFLUENZA VACCINE COMPOSITION INFLUENZA ANTIGEN FLUARIX 29/05/2002 29/05/2022 EP1392319 RM2011B049410 HYPOTENSIVE LIPID (PROSTAGLANDIN) AND TIMOLOL COMPOSITIONS AND METHODS OF USING SAME BIMATOPROST / TIMOLOLO MALEATO GANFORT 30/05/2002 30/05/2022 EP1374906 A PROCESS FOR THE PREPARATION MI2007B028216 OF PIROXICAM: BETA-CYCLODEXTRIN INCLUSION COMPOUNDS PIROXICAM BETACICLODESTRINA BREXIN CICLADOL CPR, BUSTINE, SUPP. 17/06/2002 17/06/2022 BECLOMETASONE DIPROPIONATO + FORMOTEROLO ALABASTER, FORMODUAL, FOSTER, INUVER: POLVERE PER INALAZIONE 31/07/2002 31/07/2022 EP1386630 MI2006B028898 Elenco aggiornato al 12.03.2014 POWDER INHALER Pagina 12 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione TO2005B069439 NEW PROCESS FOR THE PREPARATION OF THE TRIHYDRATE OF THE MAGNESIUM SALT OF SOMEPRAZOLE ESOMEPRAZOLE MG NEXIUM COMPRESSE 03/09/2002 03/09/2022 EP1435915 TO2008B073184 ORAL DOSAGE FORMS FOR PROPIVERINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT PROPIVERINA CLORIDRATO MICTONORM 08/10/2002 08/10/2022 EP1455781 USE OF ANASTROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL TO2008B073117 WOMEN HAVING EARLY BREAST CANCER ANASTROZOLE ARIMIDEX 06/12/2002 06/12/2022 EP1474117 TO2009B069412 COMPOSITION FOR INHALATION BUDESONIDE + FORMOTEROL SYMBICORT SINESTIC 29/01/2003 29/01/2023 EP1480679 TO2007B071180 PHARMACEUTICAL FORMULATION OF IRESSA COMPRISING A WATERSOLUBLE CELLULOSE DERIVATIVE GEFITINIB IRESSA 24/02/2003 24/02/2023 EP1485127 RM2011B050073 ADMINISTRATIONOF AGENTS FOR THE TREATMENTOF INFLAMMATION NATALIZUMAB TYSABRY 25/02/2003 25/02/2023 MI2006B035844 PROCESS FOR PREPARATION OF A STERILE SUSPENSION OF CORTICOSTEROID PARTICLES FOR THE ADMINISTRATION BY INHALATION BECLOMETASONE DIPROPIONATO BECLOMETASONE DIPROPIONATO + SALBUTAMOLO BECLONEB CLENIL PRONTINAL CLENIL COMPOSITUM: SOSP PER NEBULIZZ 15/04/2003 15/04/2023 CRESTOR 07/08/2003 07/08/2023 BONDRONAT 07/08/2003 07/08/2023 WELLBUTRIN ELONTRIL 08/08/2003 08/08/2023 IRESSA 06/09/2003 06/09/2023 EP1273581 EP1494647 EP1539711 EP1596870 EP1575565 EP1546119 PROCESS FOR PREPARING THE ROSUVASTATIN CALCIUM SALT OF ROSUVASTATIN HIGH DOSE IBANDRONATE MI2011B025554 ACIDO IBANDRONICO FORMULATION MODIFIED-RELEASE TABLET OF BUPROPIONE TO2010B068746 BUPROPION HYDROCHLORIDE CLORIDRATO PROCESS FOR THE PREPARATION OF 4- (3'CHLORO-4'-FLUOROANILINO) -7GEFITINIB TO2009B072173 METHOXY-6- (3MORPHOLINOPROPOXY) QUINAZOLINE TO2011B069304 Elenco aggiornato al 12.03.2014 Pagina 13 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione EP1393721 EP1558648 DOSAGE FORM OF POWDER AGGLOMERATES HUMAN MONOCLONAL ANTIBODIES RM2012B048801 AGAINST CD20 TO2009B067892 MOMETASONE FUROATO ASMANEX 15/09/2003 15/09/2023 OFATUMUMAB ARZERRA 17/10/2003 17/10/2023 EP1581193 MI2012B025961 BIODEGRADABLE OCULAR IMPLANT DESAMETASONE OZURDEX 07/01/2004 07/01/2024 EP1454647 TO2006B068883 INHALATION DEVICE BUDESONIDE + FORMOTEROL SYMBICORT SINESTIC 02/04/2004 02/04/2024 EP1633727 TO2010B070012 IMPROVED PRODUCTION OF THE ROSUVASTATIN CALCIUM SALT ROSUVASTATIN CRESTOR 03/06/2004 03/06/2024 EP1654263 RM2011B048799 PHOSPHORIC ACID SALT OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR SITAGLIPTIN JANUVIA 18/06/2004 18/06/2024 TO2012B070483 NEW CRYSTALLINE AND AMORPHOUS FORM OF A TRIAZOLO(4,5-D)PYRIMIDINE COMPOUND TICAGRELOR BRILIQUE 30/06/2004 30/06/2024 EP1651213 MI2009B031121 USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS, ESPECIALLY TELMISARTAN, IN ORDER TO INCREASE INSULIN SENSITIVITY TELMISARTAN + AMLODIPINA TWYNSTA 24/07/2004 24/07/2024 EP1729819 TO2008B072212 ETONOGESTREL IMPLANT IMPLANON NEXPLANON 14/03/2005 14/03/2025 EP1732548 MI2011B027695 4-AMINOPYRIDINE FAMPYRA 11/04/2005 11/04/2025 EP1781260 MI2011B019967 PRAMIPEXOLO MIRAPEXIN ER 25/07/2005 25/07/2025 EP1830816 TO2012B072228 ESOMEPRAZOLE MG NEXIUM BUSTINE 20/12/2005 20/12/2025 EP1493745 Elenco aggiornato al 12.03.2014 X-RAY VISIBLE DRUG DELIVERY DEVICE METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS EXTENDED RELEASE TABLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR MANUFACTURING THE SAME AND USE THEREOF SOLID DOSAGE FORM COMPRISING PROTON PUMP INHIBITOR AND SUSPENSION MADE THEREOF Pagina 14 di 15 Elenco dei brevetti non coperti da certificato complementare di protezione MI2012B023735 MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION POLISACCARIDE PNEUMOCOCCICO DEI SIEROTIPI 1,3,4,5,6A,6B,7F,9V,14,1 8C,19A, 19F,23F CONIUGATO E ADSORBITO PREVENAR 13 31/03/2006 31/03/2026 EP1330249 TO2006B070443 SOSTANZA FARMACEUTICADI ARIPIPRAZOLO A BASSA IGROSCOPICITA' E PROCEDIMENTI PER LA SUA PREPARAZIONE ARIPIPRAZOLO ABILIFY 25/09/2002 25/09/2022 EP2073791 MI2011B021774 CAPECITABINE PEDIATRIC TABLETS XELODA 26/09/2007 26/09/2027 EP2036549 TO2010B070108 NOVEL COMPOSITION CAPECITABINA BUDESONIDE + FORMOTEROL SYMBICORT 17/10/2008 17/10/2028 EP1868645 Elenco aggiornato al 12.03.2014 Pagina 15 di 15
© Copyright 2024 ExpyDoc
